Characterization and Prediction of Early Onset Diabetic Peripheral Neuropathy
Recruiting
Observational Study
Neuropathy, Diabetic
Small Nerve Fiber Neuropathy
Type 1 Diabetes
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 60
- Sex
- Any
- Study type
- Observational
- Participants needed
- 200 (estimated)
- Sponsor
- Aalborg University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Predicting early onset neuropathy in people with type 1 diabetes
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Men and women aged 18-80 years
* Diagnosed with diabetes (of any type)
* No clinically established diabetic peripheral neuropathy at inclusion
Exclusion Criteria:
* Alcohol or drug abuse within the last year (prior to inclusion)
* Chemotherapy (prior or within study period) …
Contacts